Skip to main content
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1983 Jun;42(3):308–310. doi: 10.1136/ard.42.3.308

Intermediate-dose intramuscular methylprednisolone acetate in the treatment of rheumatic disease.

J Kovarsky
PMCID: PMC1001138  PMID: 6602594

Abstract

Treatment with a high-dose, intravenous bolus of methylprednisolone has been reported in numerous cases of rheumatic diseases. The optimal routes of administration, dosage, dosage interval, and other factors are unknown. This report describes uncontrolled clinical observations with a single dose of 320 mg of intramuscular methylprednisolone acetate in patients with rheumatic disease (12 with rheumatoid arthritis, 2 with spondyloarthropathy). This treatment may provide a useful therapeutic adjunct in selected clinical circumstances.

Full text

PDF
308

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bocanegra T. S., Castañeda M. O., Espinoza L. R., Vasey F. B., Germain B. F. Sudden death after methylprednisolone pulse therapy. Ann Intern Med. 1981 Jul;95(1):122–122. doi: 10.7326/0003-4819-95-1-122_1. [DOI] [PubMed] [Google Scholar]
  2. Freedman M. D., Schocket A. L., Chapel N., Gerber J. G. Anaphylaxis after intravenous methylprednisolone administration. JAMA. 1981 Feb 13;245(6):607–608. [PubMed] [Google Scholar]
  3. Hess E. V., Kammen P. L. Pulse therapy in rheumatoid arthritis. Ann Intern Med. 1981 Jan;94(1):128–129. doi: 10.7326/0003-4819-94-1-128. [DOI] [PubMed] [Google Scholar]
  4. Kimberly R. P., Lockshin M. D., Sherman R. L., McDougal J. S., Inman R. D., Christian C. L. High-dose intravenous methylprednisolone pulse therapy in systemic lupus erythematosus. Am J Med. 1981 Apr;70(4):817–824. doi: 10.1016/0002-9343(81)90538-6. [DOI] [PubMed] [Google Scholar]
  5. Liebling M. R., Leib E., McLaughlin K., Blocka K., Furst D. E., Nyman K., Paulus H. E. Pulse methylprednisolone in rheumatoid arthritis: a double-blind cross-over trial. Ann Intern Med. 1981 Jan;94(1):21–26. doi: 10.7326/0003-4819-94-1-21. [DOI] [PubMed] [Google Scholar]
  6. Mintz G., Enríquez R. D., Mercado U., Robles E. J., Jiménez F. J., Gutiérrez G. Intravenous methylprednisolone pulse therapy in severe ankylosing spondylitis. Arthritis Rheum. 1981 May;24(5):734–736. doi: 10.1002/art.1780240521. [DOI] [PubMed] [Google Scholar]
  7. Pinals R. S., Masi A. T., Larsen R. A. Preliminary criteria for clinical remission in rheumatoid arthritis. Arthritis Rheum. 1981 Oct;24(10):1308–1315. doi: 10.1002/art.1780241012. [DOI] [PubMed] [Google Scholar]
  8. Stubbs S. S., Morrell R. M. Intravenous methylprednisolone sodium succinate: adverse reactions reported in association with immunosuppresive therapy. Transplant Proc. 1973 Jun;5(2):1145–1146. [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES